01 1DZD Heze Pharmaceutical Co Ltd
01 1DOXORUBICIN HYDROCHLORIDE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-08-27
Pay. Date : 2024-07-18
DMF Number : 31153
Submission : 2016-11-11
Status : Active
Type : II
20
Dzd (heze) Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is DOXORUBICIN HYDROCHLORIDE, with a corresponding US DMF Number 31153.
Remarkably, this DMF maintains an Active status since its submission on November 11, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 27, 2024, and payment made on July 18, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
